VRSKHIGH SIGNALFINANCIAL10-K

Verisk substantially increased its debt load and current liabilities while reducing share buyback activity, signaling a major shift in capital allocation strategy.

The company's total debt increased by over 50% to $4.8B while current liabilities nearly doubled to $2.3B, representing a dramatic change in the balance sheet structure that warrants close investor scrutiny. This substantial increase in leverage, combined with a 38% reduction in share buybacks, suggests either significant acquisition activity, major capital investments, or potential financial stress requiring attention.

Comparing 2026-02-18 vs 2025-02-26View on EDGAR →
FINANCIAL ANALYSIS

Verisk's balance sheet underwent a major transformation with total assets growing 45% to $6.2B, largely funded through substantially higher debt levels and current liabilities. Operating performance showed positive momentum with operating cash flow increasing 26% to $1.4B and modest growth in R&D and SG&A expenses. The sharp reduction in share buybacks to $624M from $1B, despite strong cash generation, indicates management is prioritizing debt service or other capital needs over shareholder returns.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
+85.7%
$1.2B$2.3B

Current liabilities surged 85.7% — significant near-term obligations; verify ability to meet short-term debt.

Total Debt
Balance Sheet
+54.4%
$3.1B$4.8B

Debt increased 54.4% — substantial leverage increase; assess whether deployed for growth or covering losses.

Total Assets
Balance Sheet
+45.3%
$4.3B$6.2B

Asset base grew 45.3% — expansion through organic growth, acquisitions, or capital deployment.

Total Liabilities
Balance Sheet
+41.5%
$4.2B$5.9B

Liabilities grew 41.5% — significant increase in debt or obligations, assess impact on financial flexibility.

Share Buybacks
Cash Flow
-37.9%
$1.0B$624.0M

Buyback activity reduced 37.9% — capital being redeployed elsewhere or cash conservation underway.

Operating Cash Flow
Cash Flow
+25.5%
$1.1B$1.4B

Operating cash flow grew 25.5% — strong conversion of earnings to cash, healthy business fundamentals.

R&D Expense
P&L
+15.9%
$35.3M$40.9M

R&D investment increased 15.9% — signals commitment to future product development, though near-term margin impact.

Dividends Paid
Cash Flow
+13.5%
$221.3M$251.1M

Dividend payments increased 13.5% — management confidence in sustained cash generation.

SG&A Expense
P&L
+12.1%
$408.7M$458.2M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

LANGUAGE CHANGES
NEW — 2026-02-18
PRIOR — 2025-02-26
ADDED
Shavel Chief Executive Officer, President and director true December 11, 2025 December 31, 2026 Elizabeth D.
Included in "Depreciation and amortization of fixed assets" in our accompanying condensed consolidated statements of operations Refer to Note 8.
As of February 13, 2026, there were 137,941,888 shares outstanding of the registrant's Common Stock, par value $.001.
Our subscription business model, as well as our ability to build solutions that serve the insurance industry at large, helps drive core operating leverage.
On May 23, 2008, in contemplation of our initial public offering ("IPO"), ISO formed Verisk, a Delaware corporation, to be the holding company for our business.
+7 more — sign up free →
REMOVED
Shavel Chief Executive Officer, President and director true November 25, 2024 December 31, 2025 Elizabeth D.
As of February 21, 2025, there were 140,276,165 shares outstanding of the registrant's Common Stock, par value $.001.
We also divested our specialized markets and financial services businesses in March 2022 and April 2022, respectively.
Our business aims to build upon our competitive advantages and capitalizing on our scale and position within the industry.
Our subscription business model as well as our ability to build solutions that serve the insurance industry at large helps drive core operating leverage.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →